个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
周四盘中有12只医疗保健类股走势
Gainers
- Sonnet BioTherapeutics (NASDAQ:SONN) shares moved upwards by 110.49% to $1.57 during Thursday's regular session. Trading volume for Sonnet BioTherapeutics's stock is 130.5 million as of 12:30 EST. This is 13814.69% of its average full-day volume over the last 100 days. The company's market cap stands at $33.5 million. The company's, Q3 earnings came out 3 days ago.
- Sonoma Pharmaceuticals (NASDAQ:SNOA) stock rose 82.06% to $9.85. Trading volume for this security as of 12:30 EST is 77.1 million, which is 72589.14% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.6 million. As per the press release, Q1 earnings came out 3 days ago.
- Ensysce Biosciences (NASDAQ:ENSC) shares increased by 38.97% to $4.35. As of 12:30 EST, Ensysce Biosciences's stock is trading at a volume of 27.1 million, which is 2081.16% of its average full-day volume over the last 100 days. The company's market cap stands at $105.5 million.
- InVivo Therapeutics Hldg (NASDAQ:NVIV) stock moved upwards by 29.37% to $0.77. InVivo Therapeutics Hldg's stock is trading at a volume of 3.3 million shares as of 12:30 EST. This is 404.57% of its average full-day volume over the last 100 days. The company's market cap stands at $26.2 million. As per the press release, Q2 earnings came out 4 days ago.
- Salarius Pharmaceuticals (NASDAQ:SLRX) stock increased by 21.93% to $1.06. As of 12:30 EST, Salarius Pharmaceuticals's stock is trading at a volume of 15.2 million, which is 941.44% of its average full-day volume over the last 100 days. The company's market cap stands at $47.4 million.
- XTL Biopharmaceuticals (NASDAQ:XTLB) shares rose 10.56% to $3.92. As of 12:30 EST, this security is trading at a volume of 533.2K shares, making up 555.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.7 million.
Losers
- PharmaCyte Biotech (NASDAQ:PMCB) shares decreased by 62.76% to $3.69 during Thursday's regular session. Trading volume for PharmaCyte Biotech's stock is 38.4 million as of 12:30 EST. This is 314.71% of its average full-day volume over the last 100 days. The company's market cap stands at $18.9 million.
- Ontrak (NASDAQ:OTRK) stock declined by 38.1% to $13.03. As of 12:30 EST, this security is trading at a volume of 2.4 million shares, making up 819.09% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $243.1 million.
- 180 Life Sciences (NASDAQ:ATNF) shares declined by 27.04% to $5.02. The current volume of 2.7 million shares is 757.49% of 180 Life Sciences's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $156.9 million.
- Regencell Bioscience (NASDAQ:RGC) stock fell 17.87% to $6.46. The market value of their outstanding shares is at $81.6 million.
- NRX Pharmaceuticals (NASDAQ:NRXP) shares declined by 17.23% to $11.54. As of 12:30 EST, this security is trading at a volume of 2.4 million shares, making up 52.84% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $560.8 million. As per the news, the Q2 earnings report came out 3 days ago.
- I-MAB (NASDAQ:IMAB) shares decreased by 16.5% to $56.7. I-MAB's stock is trading at a volume of 784.5K shares as of 12:30 EST. This is 113.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.3 billion.
Gainers
赢家
- Sonnet BioTherapeutics (NASDAQ:SONN) shares moved upwards by 110.49% to $1.57 during Thursday's regular session. Trading volume for Sonnet BioTherapeutics's stock is 130.5 million as of 12:30 EST. This is 13814.69% of its average full-day volume over the last 100 days. The company's market cap stands at $33.5 million. The company's, Q3 earnings came out 3 days ago.
- Sonoma Pharmaceuticals (NASDAQ:SNOA) stock rose 82.06% to $9.85. Trading volume for this security as of 12:30 EST is 77.1 million, which is 72589.14% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.6 million. As per the press release, Q1 earnings came out 3 days ago.
- Ensysce Biosciences (NASDAQ:ENSC) shares increased by 38.97% to $4.35. As of 12:30 EST, Ensysce Biosciences's stock is trading at a volume of 27.1 million, which is 2081.16% of its average full-day volume over the last 100 days. The company's market cap stands at $105.5 million.
- InVivo Therapeutics Hldg (NASDAQ:NVIV) stock moved upwards by 29.37% to $0.77. InVivo Therapeutics Hldg's stock is trading at a volume of 3.3 million shares as of 12:30 EST. This is 404.57% of its average full-day volume over the last 100 days. The company's market cap stands at $26.2 million. As per the press release, Q2 earnings came out 4 days ago.
- Salarius Pharmaceuticals (NASDAQ:SLRX) stock increased by 21.93% to $1.06. As of 12:30 EST, Salarius Pharmaceuticals's stock is trading at a volume of 15.2 million, which is 941.44% of its average full-day volume over the last 100 days. The company's market cap stands at $47.4 million.
- XTL Biopharmaceuticals (NASDAQ:XTLB) shares rose 10.56% to $3.92. As of 12:30 EST, this security is trading at a volume of 533.2K shares, making up 555.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.7 million.
- 十四行诗生物治疗学纳斯达克股票代码:SONN)股价在周四的例行交易中上涨110.49%,至1.57美元。截至美国东部时间12:30,Sonnet BioTreeutics公司股票的交易量为1.305亿美元。这是过去100日平均全天交易量的13814.69%。该公司的市值为3350万美元。该公司第三季度财报于三天前出炉。
- 索诺马制药公司纳斯达克市场代码:SNOA)股价上涨82.06%,至9.85美元。截至美国东部时间12:30,这只证券的成交量为7,710万只,是过去100日全天平均成交量的72589.14。他们流通股的市值为2060万美元。根据新闻稿,第一季度财报是在3天前发布的。
- Ensysce生物科学纳斯达克市场代码:ENSC)股价上涨38.97%,至4.35美元。截至美国东部时间12:30,Ensysce Biosciences的股票成交量为2,710万股,是过去100日全天平均成交量的2081.16%。该公司的市值为1.055亿美元。
- 体内治疗Hldg纳斯达克市场代码:NVIV)股价上涨29.37%,至0.77美元。截至美国东部时间12:30,InVivo Treateutics Hldg的股票交易量为330万股。这是过去100日平均全天交易量的404.57%。该公司的市值为2620万美元。根据新闻稿,第二季度财报是在4天前发布的。
- 沙拉瑞斯制药公司(Salarius PharmPharmticals)(纳斯达克市场代码:SLRX)股票上涨21.93%,至1.06美元。截至美国东部时间12:30,Salarius PharmPharmticals的股票成交量为1,520万口,是其过去100日全天平均成交量的941.44。该公司的市值为4740万美元。
- XTL生物制药公司纳斯达克市场代码:XTLB)股价上涨10.56%,至3.92美元。截至美国东部时间12:30,该证券成交量为533.2K股,占其过去100日全天平均成交量的555.9。他们流通股的市值为2070万美元。
Losers
失败者
- PharmaCyte Biotech (NASDAQ:PMCB) shares decreased by 62.76% to $3.69 during Thursday's regular session. Trading volume for PharmaCyte Biotech's stock is 38.4 million as of 12:30 EST. This is 314.71% of its average full-day volume over the last 100 days. The company's market cap stands at $18.9 million.
- Ontrak (NASDAQ:OTRK) stock declined by 38.1% to $13.03. As of 12:30 EST, this security is trading at a volume of 2.4 million shares, making up 819.09% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $243.1 million.
- 180 Life Sciences (NASDAQ:ATNF) shares declined by 27.04% to $5.02. The current volume of 2.7 million shares is 757.49% of 180 Life Sciences's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $156.9 million.
- Regencell Bioscience (NASDAQ:RGC) stock fell 17.87% to $6.46. The market value of their outstanding shares is at $81.6 million.
- NRX Pharmaceuticals (NASDAQ:NRXP) shares declined by 17.23% to $11.54. As of 12:30 EST, this security is trading at a volume of 2.4 million shares, making up 52.84% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $560.8 million. As per the news, the Q2 earnings report came out 3 days ago.
- I-MAB (NASDAQ:IMAB) shares decreased by 16.5% to $56.7. I-MAB's stock is trading at a volume of 784.5K shares as of 12:30 EST. This is 113.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.3 billion.
- PharmaCyte生物技术在周四的例会上,(纳斯达克市场代码:PMCB)股价下跌62.76%,至3.69美元。截至美国东部时间12:30,PharmaCyte Biotech的股票成交量为3840万股。这是过去100日平均全天交易量的314.71%。该公司的市值为1890万美元。
- Ontrak纳斯达克市场代码:OTRK)股价下跌38.1%,至13.03美元。截至美国东部时间12:30,这只证券的成交量为240万股,占其过去100日全天平均成交量的819.09。他们流通股的市值为2.431亿美元。
- 180生命科学纳斯达克市场代码:ATNF)股价下跌27.04%,至5.02美元。目前270万股的成交量是180Life Sciences过去100日全天平均成交量的757.49%(最近一次更新是在美国东部时间12:30)。他们流通股的市值为1.569亿美元。
- Regencell生物科学(纳斯达克市场代码:RGC)股价下跌17.87%,至6.46美元。他们流通股的市值为8160万美元。
- NRX制药公司纳斯达克市场代码:NRXP)股价下跌17.23%,至11.54美元。截至美国东部时间12:30,这只证券的成交量为240万股,占其过去100天的全天平均成交量的52.84%。他们流通股的市值为5.608亿美元。根据消息,第二季度的收益报告是在3天前发布的。
- 天境生物纳斯达克股票代码:IMAB)股价下跌16.5%,至56.7美元。截至美国东部时间12:30,天境生物的股票成交量为784.5K股。这是过去100日平均全天交易量的113.6%。他们流通股的市值为43亿美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!